Search Results - "Baggerly, Keith"

Refine Results
  1. 1
  2. 2

    Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes by MASUDA, Hiroko, BAGGERLY, Keith A, FRASER SYMMANS, W, UENO, Naoto T, YING WANG, YA ZHANG, GONZALEZ-ANGULO, Ana Maria, MERIC-BERNSTAM, Funda, VALERO, Vicente, LEHMANN, Brian D, PIETENPOL, Jennifer A, HORTOBAGYI, Gabriel N

    Published in Clinical cancer research (01-10-2013)
    “…The clinical relevancy of the 7-subtype classification of triple-negative breast cancer (TNBC) reported by Lehmann and colleagues is unknown. We investigated…”
    Get full text
    Journal Article
  3. 3

    Tackling the widespread and critical impact of batch effects in high-throughput data by Irizarry, Rafael A, Leek, Jeffrey T, Scharpf, Robert B, Bravo, Héctor Corrada, Simcha, David, Langmead, Benjamin, Johnson, W. Evan, Geman, Donald, Baggerly, Keith

    Published in Nature reviews. Genetics (01-10-2010)
    “…Batch effects can lead to incorrect biological conclusions but are not widely considered. The authors show that batch effects are relevant to a range of…”
    Get full text
    Journal Article
  4. 4

    Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers by Aparicio, Ana M, Shen, Li, Tapia, Elsa Li Ning, Lu, Jing-Fang, Chen, Hsiang-Chun, Zhang, Jiexin, Wu, Guanglin, Wang, Xuemei, Troncoso, Patricia, Corn, Paul, Thompson, Timothy C, Broom, Bradley, Baggerly, Keith, Maity, Sankar N, Logothetis, Christopher J

    Published in Clinical cancer research (15-03-2016)
    “…Morphologically heterogeneous prostate cancers that behave clinically like small-cell prostate cancers (SCPC) share their chemotherapy responsiveness. We asked…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    DERIVING CHEMOSENSITIVITY FROM CELL LINES: FORENSIC BIOINFORMATICS AND REPRODUCIBLE RESEARCH IN HIGH-THROUGHPUT BIOLOGY by Baggerly, Keith A., Coombes, Kevin R.

    Published in The annals of applied statistics (01-12-2009)
    “…High-throughput biological assays such as microarrays let us ask very detailed questions about how diseases operate, and promise to let us personalize therapy…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinically relevant microRNAs in ovarian cancer by Zhang, Shu, Lu, Zhen, Unruh, Anna K, Ivan, Cristina, Baggerly, Keith A, Calin, George A, Li, Zongfang, Bast, Jr, Robert C, Le, Xiao-Feng

    Published in Molecular cancer research (01-03-2015)
    “…microRNAs (miRNAs/miRs) belong to a class of small noncoding RNAs that can negatively regulate messenger RNA (mRNA) expression of target genes. miRNAs are…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability by Richards, Kristy L, Zhang, Baili, Baggerly, Keith A, Colella, Stefano, Lang, James C, Schuller, David E, Krahe, Ralf

    Published in PloS one (18-03-2009)
    “…Loss of genome-wide methylation is a common feature of cancer, and the degree of hypomethylation has been correlated with genomic instability. Global…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Functional CAR Models for Large Spatially Correlated Functional Datasets by Zhang, Lin, Baladandayuthapani, Veerabhadran, Zhu, Hongxiao, Baggerly, Keith A., Majewski, Tadeusz, Czerniak, Bogdan A., Morris, Jeffrey S.

    “…We develop a functional conditional autoregressive (CAR) model for spatially correlated data for which functions are collected on areal units of a lattice. Our…”
    Get full text
    Journal Article
  16. 16

    Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer by Yang, Wei-Lei, Gentry-Maharaj, Aleksandra, Simmons, Archana, Ryan, Andy, Fourkala, Evangelia Ourania, Lu, Zhen, Baggerly, Keith A, Zhao, Yang, Lu, Karen H, Bowtell, David, Jacobs, Ian, Skates, Steven J, He, Wei-Wu, Menon, Usha, Bast, Jr, Robert C

    Published in Clinical cancer research (01-10-2017)
    “…The tumor-suppressor gene is mutated in >95% of high-grade serous ovarian cancers. Detecting an autologous antibody response to TP53 that might improve early…”
    Get full text
    Journal Article
  17. 17

    Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis by Jinesh, Goodwin G., Manyam, Ganiraju C., Mmeje, Chinedu O., Baggerly, Keith A., Kamat, Ashish M.

    Published in Scientific reports (29-08-2017)
    “…Cancer cells require both migratory and tumorigenic property to establish metastatic tumors outside the primary microenvironment. Identifying the…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20